A phase II study of docetaxel (Taxotere), estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: Preliminary results of cancer and leukemia group B trial 9780

Authors
Savarese, D Taplin, ME Halabi, S Hars, V Kreis, W Vogelzang, N
Citation
D. Savarese et al., A phase II study of docetaxel (Taxotere), estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: Preliminary results of cancer and leukemia group B trial 9780, SEMIN ONCOL, 26(5), 1999, pp. 39-44
Citations number
28
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
SEMINARS IN ONCOLOGY
ISSN journal
00937754 → ACNP
Volume
26
Issue
5
Year of publication
1999
Supplement
17
Pages
39 - 44
Database
ISI
SICI code
0093-7754(199910)26:5<39:APISOD>2.0.ZU;2-4